Succinate-to-fumarate ratio as a new metabolic marker to detect the presence of sdhb/d-related paraganglioma: Initial experimental and ex vivo findings

Endocrinology

Volumn 155, Issue 1, 2014, Pages 27-32

  Lendvai, Nikoletta ^a,b   Pawlosky, Robert ^c   Bullova, Petra ^a,d   Eisenhofer, Graeme ^e   Patocs, Attila ^f,g   Veech, Richard L ^c   Pacak, Karel ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^c NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^d INSTITUTE OF VIROLOGY   (Slovakia)

^e UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^f INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^g SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

FUMARIC ACID; SUCCINATE DEHYDROGENASE; SUCCINATE DEHYDROGENASE SUBUNIT B; SUCCINIC ACID; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CITRIC ACID CYCLE; CONTROLLED STUDY; EX VIVO STUDY; GENE DELETION; GENE EXPRESSION; GENE MUTATION; GENE SILENCING; HUMAN; HUMAN TISSUE; MASS SPECTROMETRY; MOUSE; NEUROFIBROMATOSIS; NONHUMAN; PARAGANGLIOMA; PHEOCHROMOCYTOMA; PRIORITY JOURNAL;

EID: 84891388086     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2013-1549     Document Type: Article

References (27)

1. Gimenez-Roqueplo AP, Dahia PL, Robledo M. An update on the genetics of paraganglioma, pheochromocytoma, and associated hereditary syndromes. Horm Metab Res. 2012;44:328-333.
2. Baysal BE, Ferrell RE, Willett-Brozick JE, et al. Mutations inSDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science. 2000;287:848-851.
3. Niemann S, Müller U. Mutations in SDHC cause autosomal dominant paraganglioma, type 3. Nat Genet. 2000;26:268-270.
4. Astuti D, Latif F, Dallol A, et al. Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. Am J Hum Genet. 2001;69:49-54.
5. Hao HX, Khalimonchuk O, Schraders M, et al. SDH5, a gene required for flavination of succinate dehydrogenase, is mutated in paraganglioma. Science. 2009;325:1139-1142.
6. Burnichon N, Brière JJ, Libé R, et al. SDHA is a tumor suppressor gene causing paraganglioma. Hum Mol Genet. 2010;19:3011-3020.
7. Gimenez-Roqueplo AP, Favier J, Rustin P, et al COMETE Network. Mutations in the SDHB gene are associated with extra-Adrenal and/or malignant phaeochromocytomas. Cancer Res. 2003;63: 5615-5621.
8. Timmers HJ, Kozupa A, Eisenhofer G, et al. Clinical presentations, biochemical phenotypes, and genotype-phenotype correlations in patients with SDHB-Associated pheochromocytomas and paragangliomas. J Clin Endocrinol Metab. 2007;92:779-786.
9. Eisenhofer G, Lenders JW, Siegert G, et al. Plasma methoxytyramine: A novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumour size, location and SDHB mutation status. Eur J Cancer. 2012;48:1739-1749.
10. Pollard PJ, Brière JJ, Alam NA, et al. Accumulation of Krebs cycle intermediates and over-expression of HIF1- in tumours which result from germline FH and SDH mutations. Hum Mol Genet. 2005; 14:2231-2239.
11. Pawlu C, Bausch B, Reisch N, Neumann HP. Genetic testing for pheochromocytoma-Associated syndromes. Ann Endocrinol (Paris). 2005;66:178-185.
12. van Nederveen FH, Gaal J, Favier J, et al. An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: A retrospective and prospective analysis. Lancet Oncol. 2009;10: 764-771.
13. Baysal BE. On the association of succinate dehydrogenase mutations with hereditary paraganglioma. Trends Endocrinol Metab. 2003;14:453-459.
14. Dahia PL, RossKN,WrightME,et al.AHIF1α regulatory loop links hypoxia and mitochondrial signals in pheochromocytomas. PLoS Genet. 2005;1:72-80.
15. Xiao M, Yang H,XuW, et al. Inhibition of α-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors. Genes Dev. 2012;26:1326-1338.
16. Powers JF, Evinger MJ, Tsokas P, et al. Pheochromocytoma cell lines from heterozygous neurofibromatosis knockout mice. Cell Tissue Res. 2000;302:309-320.
17. Martiniova L, Lai EW, Elkahloun AG, et al. Characterization of an animal model of aggressive metastatic pheochromocytoma linked to a specific gene signature. Clin Exp Metastasis. 2009;26:239-250.
18. Pawlosky RJ, Kashiwaya Y, Srivastava S, et al. Alterations in brain glucose utilization accompanying elevations in blood ethanol and acetate concentrations in the rat. Alcohol Clin Exp Res. 2010;34: 375-381.
19. Gottlieb E, Tomlinson IP. Mitochondrial tumour suppressors: A genetic and biochemical update. Nat Rev Cancer. 2005;5:857-866.
20. Selak MA, Armour SM, MacKenzie ED, et al. Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-α prolyl hydroxylase. Cancer Cell. 2005;7:77-85.
21. Semenza GL, Wang GL. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol. 1992;12:5447-5454.
22. Semenza GL, Roth PH, Fang HM, Wang GL. Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J Biol Chem. 1994;269:23757-23763.
23. Ishii T, Yasuda K, Akatsuka A, Hino O, Hartman PS, Ishii N. A mutation in the SDHC gene of complex II increases oxidative stress, resulting in apoptosis and tumorigenesis. Cancer Res. 2005;65:203-209.
24. Guzy RD, Sharma B, Bell E, Chandel NS, Schumacker PT. Loss of the SdhB, but not the SdhA, subunit of complex II triggers reactive oxygen species-dependent hypoxia-inducible factor activation and tumorigenesis. Mol Cell Biol. 2008;28:718-731.
25. LinehanWM,Srinivasan R, Schmidt LS. The genetic basis of kidney cancer: A metabolic disease. Nat Rev Urol. 2010;7:277-285.
26. Fiehn O. Metabolomics - the link between genotypes and phenotypes. Plant Mol Biol. 2002;48:155-171.
27. Yang C, Matro JC, Huntoon KM, et al. Missense mutations in the human SDHB gene increase protein degradation without altering intrinsic enzymatic function. FASEB J. 2012;26:4506-4516.